Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.

about

Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.

P2860

Q40290559-119D4485-BC08-4B24-878B-867E31606E2B

P2860

Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.

Item

http://www.wikidata.org/entity/Q48719284

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@en

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@nl

type

Item

label

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@en

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@nl

prefLabel

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@en

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@nl

P1476

Reliability of the Ki67-Labell ...... s Unaffected by Biopsy Volume.

@en

P2093

C M Focke

http://www.w3.org/2001/XMLSchema#string

P J van Diest

http://www.w3.org/2001/XMLSchema#string

T Decker

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarker validation and testing

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.

Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays

Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

P2888

s10434-016-5730-1

P304

1251-1257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-016-5730-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003933442

http://www.w3.org/2001/XMLSchema#string

P698

28008571

http://www.w3.org/2001/XMLSchema#string

P921

biopsy

Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.

about

P2860

P2860

Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921